Zhejiang Jolly Pharmaceutical Co Ltd (300181):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Zhejiang Jolly Pharmaceutical Co Ltd (300181) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9383
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:中国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Zhejiang Jolly Pharmaceutical Co Ltd (Zhejiang Jolly Pharma) is a producer and marketer of pharmaceutical products. The company offers products in the form of tablets, capsules, granules, injections, dry powders, and others. Its products include Wuling powder, pseudomonas moth powder, cordyceps cephalosporin, powder, Wuling capsule, bailing tablet, azithromycin, doxapram, pefloxacin mesylate and clindamycin phosphate. Zhejiang Jolly Pharma provides Linglianhua particle for menopausal syndrome treatment. The company also adopts medicinal fungi to produce traditional Chinese medicinal products based on bio-fermentation technology. It exports its products to Britain, Singapore, Japan, Malaysia, Croatia, Serbia, Vietnam, Hong Kong, Macao, the US, and other countries. The company operates its subsidiaries in China. Zhejiang Jolly Pharma is headquartered in Huzhou, China.

Zhejiang Jolly Pharmaceutical Co Ltd (300181) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Zhejiang Jolly Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Zhejiang Jolly Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Zhejiang Jolly Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Zhejiang Jolly Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Zhejiang Jolly Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Zhejiang Jolly Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Equity Offering 10
Zhejiang Jolly Pharma Plans to Raise up to USD79 Million in Private Placement of Shares 10
Debt Offering 11
Zhejiang Jolly Pharmaceutical Plans to Raise USD129.5 Million in Private Placement of Bonds Due 2021 11
Zhejiang Jolly Pharma to Raise USD78 Million in Public Offering of Bonds 12
Acquisition 13
Zhejiang Jolly Pharma to Sell 85% Stake in Pharmaceutical Company for USD3.2 Million 13
Zhejiang Jolly Pharma Acquires 27.46% Stake in Baicao Traditional Chinese Medicine 14
Zhejiang Jolly Pharmaceutical Co Ltd – Key Competitors 15
Zhejiang Jolly Pharmaceutical Co Ltd – Locations And Subsidiaries 16
Head Office 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Zhejiang Jolly Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Zhejiang Jolly Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Zhejiang Jolly Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Zhejiang Jolly Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Zhejiang Jolly Pharmaceutical Co Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Zhejiang Jolly Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Zhejiang Jolly Pharma Plans to Raise up to USD79 Million in Private Placement of Shares 10
Zhejiang Jolly Pharmaceutical Plans to Raise USD129.5 Million in Private Placement of Bonds Due 2021 11
Zhejiang Jolly Pharma to Raise USD78 Million in Public Offering of Bonds 12
Zhejiang Jolly Pharma to Sell 85% Stake in Pharmaceutical Company for USD3.2 Million 13
Zhejiang Jolly Pharma Acquires 27.46% Stake in Baicao Traditional Chinese Medicine 14
Zhejiang Jolly Pharmaceutical Co Ltd, Key Competitors 15

List of Figures
Zhejiang Jolly Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Zhejiang Jolly Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Zhejiang Jolly Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Zhejiang Jolly Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Zhejiang Jolly Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Zhejiang Jolly Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Zhejiang Jolly Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Zhejiang Jolly Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Zhejiang Jolly Pharmaceutical Co Ltd (300181):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • EnerVest Ltd:企業のM&A・事業提携・投資動向
    EnerVest Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's EnerVest Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, …
  • Horizon Oil Ltd (HZN):石油・ガス:M&Aディール及び事業提携情報
    Summary Horizon Oil Ltd (Horizon) is an oil and gas exploration and production company that acquires, explores, develops and produces oil and petroleum properties. The company holds interests in Maari and Manaia fields located in the Taranaki Basin approximately 80 kilometre offshore the north islan …
  • HepQuant Llc:企業の製品パイプライン分析2018
    Summary Hepquant LLC (Hepquant) is a medical device company that offers diagnostic products. The company develops and markets patented and patent-pending technology for assessing liver function of patients with chronic liver disease. It offers investigational combination drug and diagnostic devices. …
  • EOS imaging SA (EOSI):医療機器:M&Aディール及び事業提携情報
    Summary EOS imaging SA (EOS Imaging) is an orthopedic imaging company that designs, develops, and markets EOS patented medical imaging system. EOS captures whole body images of a standing patient in a single scan without any stitching or vertical distortion. Through EOS, the company provides the ful …
  • SoftwareONE Holding AG (SWON):企業の財務・戦略的SWOT分析
    SoftwareONE Holding AG (SWON) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Nick Scali Ltd (NCK):企業の財務・戦略的SWOT分析
    Nick Scali Ltd (NCK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Ahimsa Industries Limited:戦略・SWOT・企業財務分析
    Ahimsa Industries Limited - Strategy, SWOT and Corporate Finance Report Summary Ahimsa Industries Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • National Instruments Corp (NATI):企業の財務・戦略的SWOT分析
    National Instruments Corp (NATI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • The Shoko Chukin Bank, Ltd.:企業の戦略・SWOT・財務情報
    The Shoko Chukin Bank, Ltd. - Strategy, SWOT and Corporate Finance Report Summary The Shoko Chukin Bank, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Utair Aviation
    Utair Aviation - Strategy, SWOT and Corporate Finance Report Summary Utair Aviation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Altius Minerals Corporation:企業のM&A・事業提携・投資動向
    Altius Minerals Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Altius Minerals Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acq …
  • Merit Medical Systems Inc (MMSI):企業の製品パイプライン分析2018
    Summary Merit Medical Systems, Inc. (Merit Medical) offers a wide range of single-use medical devices for interventional and diagnostic procedures. The company’s products include inflation devices and accessories, diagnostic and therapeutic catheters, diagnostic and hydrophilic products, thrombolyti …
  • World Fuel Services Corp (INT):企業の財務・戦略的SWOT分析
    World Fuel Services Corp (INT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • PetroRio SA (PRIO3):石油・ガス:M&Aディール及び事業提携情報
    Summary PetroRio SA (PetroRio), formerly HRT Participacoes em Petroleo SA, a subsidiary of HRT Oil & Gas Ltd, is oil and gas company that offers investment and recovering of oil production assets. The company offers development of solid growth platforms aiming to generate value to its shareholders b …
  • The Broad Institute Inc:医療機器:M&Aディール及び事業提携情報
    Summary The Broad Institute Inc (Broad Institute), a subsidiary of The Broad Foundation is a non-profit research organization that conducts genomic research for treatment of human diseases. The organization transforms medicine by utilizing systematic approaches in biological sciences, to speed up th …
  • Histogen Inc-医療機器分野:企業M&A・提携分析
    Summary Histogen Inc (Histogen) is a regenerative medicine company that develops novel therapies. The company offers research and develops cell based products. Its products include insoluble human extracellular matrix and a soluble complex of proteins. Histogen’s proprietary technologies are used in …
  • Hokkaido Gas Co Ltd (9534):企業の財務・戦略的SWOT分析
    Summary Hokkaido Gas Co Ltd (Hokkaido Gas), a subsidiary of Kita Gas Group is an oil and gas company that distributes petroleum products. The company’s business activities include gas business, heat supply, power supply, purification and sale of gas by-products, and production and sale of gas applia …
  • Gamma Solutions SL:電力:M&Aディール及び事業提携情報
    Summary Gamma Solutions SL (Gamma Solutions) is an engineering and consulting company that operates through energy, telecommunication, mobile and IT, and research and development divisions. The company offers products such as gamma start city monitoring system, photovoltaic rooftop monitoring system …
  • United Rentals Inc:戦略・SWOT・企業財務分析
    United Rentals Inc - Strategy, SWOT and Corporate Finance Report Summary United Rentals Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Bank Audi SAL:企業の戦略・SWOT・財務分析
    Bank Audi SAL - Strategy, SWOT and Corporate Finance Report Summary Bank Audi SAL - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆